Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Bartlett

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|August 28, 2013
Lack of protease inhibitor resistance following treatment failure--too good to be true?John A Bartlett
Infectious Diseases and Therapy|August 20, 2014
Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIVDorothy E Dow, John A Bartlett
The Lancet. Infectious Diseases|September 26, 2009
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countriesJohn A Bartlett, John F Shao
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|March 3, 2007
Generic and branded drugs for the treatment of people living with HIV/AIDSJohn A Bartlett, Eva P Muro
Expert Review of Anti-Infective Therapy|November 26, 2005
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infectionAlbert M L Anderson, John A Bartlett
Current HIV/AIDS Reports|April 13, 2006
Changing antiretroviral therapy in the setting of virologic relapse: review of the current literatureAlbert M L Anderson, John A Bartlett
HIV Clinical Trials|August 28, 2007
Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overviewJohn A Bartlett, Shan-Shan Chen, Joseph B Quinn
Antiviral Therapy|November 21, 2007
Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infectionAlbert M L Anderson, Andrzej S Kosinski, John A Bartlett
AIDS Clinical Care|January 4, 2006
Antiretroviral rounds. A communication conundrumKeith Henry, John A Bartlett, Erna Kojic, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 2, 2009
Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settingsJohn A Bartlett, John Hornberger, Ashwini Shewade, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|August 28, 2013
Lack of protease inhibitor resistance following treatment failure--too good to be true?John A Bartlett
Infectious Diseases and Therapy|August 20, 2014
Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIVDorothy E Dow, John A Bartlett
The Lancet. Infectious Diseases|September 26, 2009
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countriesJohn A Bartlett, John F Shao
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|March 3, 2007
Generic and branded drugs for the treatment of people living with HIV/AIDSJohn A Bartlett, Eva P Muro
Expert Review of Anti-Infective Therapy|November 26, 2005
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infectionAlbert M L Anderson, John A Bartlett
Current HIV/AIDS Reports|April 13, 2006
Changing antiretroviral therapy in the setting of virologic relapse: review of the current literatureAlbert M L Anderson, John A Bartlett
HIV Clinical Trials|August 28, 2007
Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overviewJohn A Bartlett, Shan-Shan Chen, Joseph B Quinn
Antiviral Therapy|November 21, 2007
Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infectionAlbert M L Anderson, Andrzej S Kosinski, John A Bartlett
AIDS Clinical Care|January 4, 2006
Antiretroviral rounds. A communication conundrumKeith Henry, John A Bartlett, Erna Kojic, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 2, 2009
Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settingsJohn A Bartlett, John Hornberger, Ashwini Shewade, et al.
Pageof 9